A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD
Public ClinicalTrials.gov record NCT05149664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Non-significant Risk Clinical Study to Assess Changes in Perfusion Resulting From Application of the VibratoSleeve, a Therapeutic Ultrasound (TUS) Phased Array, for Patients With Peripheral Arterial Disease (PAD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
All evaluable subjects will receive VibratoSleeve therapeutic ultrasound (TUS) treatments. The device will be programmed to deliver TUS at a pre-determined level. Three different acoustic intensity levels will be tested during the first three treatment visits (one at each visit day). The most effective treatment that is comfortable to a subject will be prescribed for the remaining treatment sessions. Treatment time will be 90 minutes per session, one session per day. Thirty treatment sessions will be performed over a 45-day period. Subjects will appear for on-site follow-up visits at 1-, 3-, and 6-months following subject's last (30th) treatment session.
Study identification
- NCT ID
- NCT05149664
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 13, 2022
- Primary completion
- Feb 9, 2023
- Completion
- Nov 30, 2023
- Last update posted
- May 22, 2023
2022 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vascular & Interventional Specialists of Orange County | Orange | California | 92868 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Peripheral Arterial Disease (PAD) trials
Other public records listing Peripheral Arterial Disease (PAD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07637396: Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait Not yet recruiting
- NCT07613840: Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Recruiting
- NCT07597239: Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization Active, not recruiting
- NCT06457685: Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial Active, not recruiting
- NCT07016698: Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05149664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2023 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05149664 live on ClinicalTrials.gov.